The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 26, 2018

Filed:

Jun. 04, 2014
Applicant:

Idenix Pharmaceuticals Llc, Cambridge, MA (US);

Inventors:

David Dukhan, Saint Gely du Fesc, FR;

Gilles Gosselin, Montpellier, FR;

Cyril B. Dousson, Canet, FR;

Assignee:

IDENIX PHARMACEUTICALS LLC, Cambridge, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 409/04 (2006.01); C07D 473/18 (2006.01); A61K 31/506 (2006.01); A61K 31/522 (2006.01); A61K 45/06 (2006.01); C07H 19/067 (2006.01);
U.S. Cl.
CPC ...
C07D 473/18 (2013.01); A61K 31/506 (2013.01); A61K 31/522 (2013.01); A61K 45/06 (2013.01); C07D 409/04 (2013.01); C07H 19/067 (2013.01);
Abstract

Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 1',4′-thio nucleoside compounds which display remarkable efficacy and bioavailability for the treatment of, for example, HCV infection in a human. In certain embodiments, the compounds are of Formula 3001: or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof; wherein Base, R, R, W, X, Y, and Z are as described herein.


Find Patent Forward Citations

Loading…